• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CD27 激动剂与 CD28 和 4-1BB 信号协同作用,增强了 CAR-T 细胞在结直肠肿瘤中的疗效。

CD27 agonism coordinates with CD28 and 4-1BB signal to augment the efficacy of CAR-T cells in colorectal tumor.

机构信息

Department of hepatobiliary surgery, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, 400038, China.

Department of general surgery, General Hospital of central theater command, Wuhan, 430000, China.

出版信息

Med Oncol. 2023 Mar 22;40(4):123. doi: 10.1007/s12032-023-01959-1.

DOI:10.1007/s12032-023-01959-1
PMID:36944898
Abstract

Chimeric antigen receptor T cell (CAR-T) is regarded as a promising therapy for malignancies. In our previous clinical trial targeted colorectal tumors, we found that CAR-T cells experienced poor proliferation and persistence in tumor sites. To improve the efficacy of CAR-T cells, we introduced CD27 co-stimulation signal into the established system and found that the CEA28BB27Z CAR-T cells exhibited enhanced proliferation and anti-tumor activity. Next, we demonstrated that the CEA28BB27Z CAR-T cells expressed less immune checkpoint receptors and generated more CD4 and CD8 memory stem T (T) cells compared with other CARs during constant antigen stimulation. Furthermore, our data revealed that the different combination of co-stimulation signal affected the mitochondrial dynamics of CAR-T cells, and CEA28BB27Z CAR-T cells maintained more fused mitochondrial network compared with others. Finally, we validated the superior antitumor capacity of the CEA28BB27Z CAR-T cells in xenograft models. Our findings suggest that CD27 co-stimulation signals play a key role in improving the anti-tumor efficacy of CAR-T cells.

摘要

嵌合抗原受体 T 细胞(CAR-T)被认为是治疗恶性肿瘤的一种有前途的疗法。在我们之前针对结直肠肿瘤的临床试验中,我们发现 CAR-T 细胞在肿瘤部位的增殖和持久性较差。为了提高 CAR-T 细胞的疗效,我们在已建立的系统中引入了 CD27 共刺激信号,发现 CEA28BB27Z CAR-T 细胞表现出增强的增殖和抗肿瘤活性。接下来,我们证明与其他 CAR 相比,CEA28BB27Z CAR-T 细胞在持续抗原刺激下表达较少的免疫检查点受体,并产生更多的 CD4 和 CD8 记忆性干 T(T)细胞。此外,我们的数据表明,不同的共刺激信号组合会影响 CAR-T 细胞的线粒体动力学,与其他 CAR 相比,CEA28BB27Z CAR-T 细胞保持更多融合的线粒体网络。最后,我们在异种移植模型中验证了 CEA28BB27Z CAR-T 细胞的优越抗肿瘤能力。我们的研究结果表明,CD27 共刺激信号在提高 CAR-T 细胞的抗肿瘤疗效方面发挥着关键作用。

相似文献

1
CD27 agonism coordinates with CD28 and 4-1BB signal to augment the efficacy of CAR-T cells in colorectal tumor.CD27 激动剂与 CD28 和 4-1BB 信号协同作用,增强了 CAR-T 细胞在结直肠肿瘤中的疗效。
Med Oncol. 2023 Mar 22;40(4):123. doi: 10.1007/s12032-023-01959-1.
2
A novel chimeric antigen receptor containing a JAK-STAT signaling domain mediates superior antitumor effects.一种新型嵌合抗原受体,包含 JAK-STAT 信号域,介导优越的抗肿瘤效应。
Nat Med. 2018 Mar;24(3):352-359. doi: 10.1038/nm.4478. Epub 2018 Feb 5.
3
CD27 enhances the killing effect of CAR T cells targeting trophoblast cell surface antigen 2 in the treatment of solid tumors.CD27增强靶向滋养层细胞表面抗原2的嵌合抗原受体T细胞在实体瘤治疗中的杀伤作用。
Cancer Immunol Immunother. 2021 Jul;70(7):2059-2071. doi: 10.1007/s00262-020-02838-8. Epub 2021 Jan 13.
4
4-1BB Signaling Boosts the Anti-Tumor Activity of CD28-Incorporated 2 Generation Chimeric Antigen Receptor-Modified T Cells.4-1BB 信号增强了嵌合抗原受体修饰的 CD28 整合第二代 T 细胞的抗肿瘤活性。
Front Immunol. 2020 Nov 13;11:539654. doi: 10.3389/fimmu.2020.539654. eCollection 2020.
5
4-1BB and optimized CD28 co-stimulation enhances function of human mono-specific and bi-specific third-generation CAR T cells.4-1BB 共刺激和优化的 CD28 共刺激增强了人单特异性和双特异性第三代 CAR T 细胞的功能。
J Immunother Cancer. 2021 Oct;9(10). doi: 10.1136/jitc-2021-003354.
6
Combined CD28 and 4-1BB Costimulation Potentiates Affinity-tuned Chimeric Antigen Receptor-engineered T Cells.联合CD28和4-1BB共刺激增强亲和力优化的嵌合抗原受体工程化T细胞。
Clin Cancer Res. 2019 Jul 1;25(13):4014-4025. doi: 10.1158/1078-0432.CCR-18-2559. Epub 2019 Apr 12.
7
Secretion of 4-1BB Ligand Crosslinked to PD-1 Checkpoint Inhibitor Potentiates Chimeric Antigen Receptor T Cell Solid Tumor Efficacy.4-1BB 配体与 PD-1 检查点抑制剂交联的分泌增强嵌合抗原受体 T 细胞实体瘤疗效。
Hum Gene Ther. 2023 Nov;34(21-22):1145-1161. doi: 10.1089/hum.2022.068. Epub 2023 Apr 20.
8
Redirecting T Cells to Glypican-3 with 4-1BB Zeta Chimeric Antigen Receptors Results in Th1 Polarization and Potent Antitumor Activity.利用4-1BB ζ嵌合抗原受体将T细胞重定向至磷脂酰肌醇蛋白聚糖-3可导致Th1极化和强大的抗肿瘤活性。
Hum Gene Ther. 2017 May;28(5):437-448. doi: 10.1089/hum.2016.025. Epub 2016 Aug 16.
9
Co-Stimulatory Receptor Signaling in CAR-T Cells.嵌合抗原受体 T 细胞共刺激受体信号。
Biomolecules. 2022 Sep 15;12(9):1303. doi: 10.3390/biom12091303.
10
Regional Delivery of Chimeric Antigen Receptor-Engineered T Cells Effectively Targets HER2 Breast Cancer Metastasis to the Brain.嵌合抗原受体修饰 T 细胞的区域性递送可有效靶向 HER2 阳性乳腺癌脑转移。
Clin Cancer Res. 2018 Jan 1;24(1):95-105. doi: 10.1158/1078-0432.CCR-17-2041. Epub 2017 Oct 23.

引用本文的文献

1
Adoptive cell therapy in colorectal cancer: Advances in chimeric antigen receptor T cells.结直肠癌中的过继性细胞疗法:嵌合抗原受体T细胞的进展
World J Gastrointest Oncol. 2025 Jul 15;17(7):106723. doi: 10.4251/wjgo.v17.i7.106723.
2
Deciphering T-cell exhaustion in the tumor microenvironment: paving the way for innovative solid tumor therapies.解析肿瘤微环境中的T细胞耗竭:为创新实体瘤疗法铺平道路。
Front Immunol. 2025 Apr 1;16:1548234. doi: 10.3389/fimmu.2025.1548234. eCollection 2025.
3
The role of mitochondrial biogenesis, mitochondrial dynamics and mitophagy in gastrointestinal tumors.

本文引用的文献

1
CAR T cell therapy for breast cancer: harnessing the tumor milieu to drive T cell activation.嵌合抗原受体 T 细胞疗法治疗乳腺癌:利用肿瘤微环境驱动 T 细胞激活。
J Immunother Cancer. 2018 May 10;6(1):34. doi: 10.1186/s40425-018-0347-5.
2
CXCR4 Promotes Neuroblastoma Growth and Therapeutic Resistance through miR-15a/16-1-Mediated ERK and BCL2/Cyclin D1 Pathways.CXCR4 通过 miR-15a/16-1 介导的 ERK 和 BCL2/Cyclin D1 通路促进神经母细胞瘤的生长和治疗抵抗。
Cancer Res. 2018 Mar 15;78(6):1471-1483. doi: 10.1158/0008-5472.CAN-17-0454. Epub 2017 Dec 19.
3
Safety and Efficacy of Intratumoral Injections of Chimeric Antigen Receptor (CAR) T Cells in Metastatic Breast Cancer.
线粒体生物发生、线粒体动力学及线粒体自噬在胃肠道肿瘤中的作用
Cancer Cell Int. 2025 Feb 15;25(1):46. doi: 10.1186/s12935-025-03685-2.
4
Expanded Alternatives of CRISPR-Cas9 Applications in Immunotherapy of Colorectal Cancer.CRISPR-Cas9 应用在结直肠癌免疫治疗中的扩展选择。
Mol Diagn Ther. 2024 Jan;28(1):69-86. doi: 10.1007/s40291-023-00680-z. Epub 2023 Oct 31.
嵌合抗原受体(CAR)T 细胞瘤内注射治疗转移性乳腺癌的安全性和疗效。
Cancer Immunol Res. 2017 Dec;5(12):1152-1161. doi: 10.1158/2326-6066.CIR-17-0189. Epub 2017 Nov 6.
4
Mitochondrial Priming by CD28.CD28介导的线粒体启动
Cell. 2017 Oct 5;171(2):385-397.e11. doi: 10.1016/j.cell.2017.08.018. Epub 2017 Sep 14.
5
Phase I Escalating-Dose Trial of CAR-T Therapy Targeting CEA Metastatic Colorectal Cancers.靶向癌胚抗原的嵌合抗原受体T细胞疗法用于转移性结直肠癌的I期剂量递增试验。
Mol Ther. 2017 May 3;25(5):1248-1258. doi: 10.1016/j.ymthe.2017.03.010. Epub 2017 Mar 31.
6
T memory stem cells in health and disease.健康与疾病中的T记忆干细胞。
Nat Med. 2017 Jan 6;23(1):18-27. doi: 10.1038/nm.4241.
7
Mitochondrial Dynamics Controls T Cell Fate through Metabolic Programming.线粒体动力学通过代谢编程控制T细胞命运。
Cell. 2016 Jun 30;166(1):63-76. doi: 10.1016/j.cell.2016.05.035. Epub 2016 Jun 9.
8
Clinical blockade of PD1 and LAG3--potential mechanisms of action.临床阻断 PD1 和 LAG3——潜在的作用机制。
Nat Rev Immunol. 2015 Jan;15(1):45-56. doi: 10.1038/nri3790.
9
Chimeric antigen receptor T cells for ALL.用于治疗急性淋巴细胞白血病的嵌合抗原受体T细胞
Lancet. 2015 Feb 7;385(9967):488-90. doi: 10.1016/S0140-6736(14)61729-3. Epub 2014 Oct 13.
10
Chimeric antigen receptor T cells for sustained remissions in leukemia.用于白血病持续缓解的嵌合抗原受体T细胞。
N Engl J Med. 2014 Oct 16;371(16):1507-17. doi: 10.1056/NEJMoa1407222.